Helio Genomics

Helio Genomics Helio Genomics (formerly Helio Health) is headquartered in the United States with offices in California, Texas, and Indiana.

Helio Genomics (formerly Helio Health) is an AI-driven healthcare company focused on developing and commercializing early cancer detection tests from a simple blood draw. Helio Genomics is a multinational business with collaborations in both the United States and China, including leading scientists, physicians, research institutions, and business leaders from both countries. Helio Genomics strives to combine the experiences of these innovators and achievers in order to provide the healthiest and safest diagnostic technologies to everyone. Helio Genomics has CLIA and CAP certified laboratories, 3rd party laboratories, and cGMP facilities all working towards the endeavor of bringing these first-class technologies into the medical community.

Happy New Year! We are excited for what 2023 has in store for  . Our mission is to save lives by detecting cancer early ...
01/01/2023

Happy New Year! We are excited for what 2023 has in store for . Our mission is to save lives by detecting cancer early and to provide peace of mind for you and your families. #2023

Stay Connected With Us! Subscribe to our newsletter for the latest updates on our journey to defeat cancer. Link here: h...
12/28/2022

Stay Connected With Us! Subscribe to our newsletter for the latest updates on our journey to defeat cancer. Link here: https://bit.ly/3Gg6qX9

Merry Christmas from   ! We wish you lots of love, joy, happiness and good health this holiday season.
12/25/2022

Merry Christmas from ! We wish you lots of love, joy, happiness and good health this holiday season.

Are you up to date with your early cancer detection guidelines? Studies have shown that Helio’s criteria to select and i...
12/21/2022

Are you up to date with your early cancer detection guidelines? Studies have shown that Helio’s criteria to select and investigate certain genes is more robust and precise, suggesting HelioLiver’s markers are more biologically relevant than competitor tests that utilize other genes.

One of our biggest accomplishments this year has been our ENCORE publication in Hepatology Communications. Read the full...
12/16/2022

One of our biggest accomplishments this year has been our ENCORE publication in Hepatology Communications. Read the full journal article here: https://bit.ly/3uYuvLO

Our CEO, Justin Chen Li was recently interviewed by Sinan Kanatsiz with the Internet Marketing Association. Click the li...
12/12/2022

Our CEO, Justin Chen Li was recently interviewed by Sinan Kanatsiz with the Internet Marketing Association. Click the link to watch the full interview and get an inside scoop on what the future looks like for Helio Genomics.

Link here: https://bit.ly/3iXHElg

It’s time to change the way you think about healthcare. CEO of HelioGenomics, Justin Li, discusses how AI is advancing traditional medical practices to save ...

Our CEO, Justin Chen Li, was interviewed in Park City, Utah at  . Justin speaks about the origin of   and how to use art...
12/06/2022

Our CEO, Justin Chen Li, was interviewed in Park City, Utah at . Justin speaks about the origin of and how to use artificial intelligence to effectively detect cancer. Watch the video to learn more!

We recently took part in the Internet Marketing Association’s IMPACT 22 conference, which took place in Park City, Utah. Our CEO, Justin Chen Li, was intervi...

Happy Thanksgiving from Helio Genomics! We're grateful to have a hardworking organization dedicated to saving lives thro...
11/24/2022

Happy Thanksgiving from Helio Genomics! We're grateful to have a hardworking organization dedicated to saving lives through early cancer detection and to be working with dedicated physicians who believe in our cause.

  is a DNA-based test that examines a person’s specific genetic markup. When cells shed DNA into the bloodstream, that b...
11/18/2022

is a DNA-based test that examines a person’s specific genetic markup. When cells shed DNA into the bloodstream, that becomes “cell-free DNA”, or cfDNA. HelioLiver utilizes innovative new technology to isolate cfDNA from blood samples and analyzes for signs of cancer.

HelioLiver offers a reliable and accessible approach to testing as a simple blood draw and has been validated in clinica...
11/11/2022

HelioLiver offers a reliable and accessible approach to testing as a simple blood draw and has been validated in clinical studies with promising results. Ultrasound is the standard of care for liver surveillance, yet is widely perceived by physicians as inadequate, owing both to performance factors and barriers to patients receiving the ultrasound.

It is not too late to register for the live webinar today at 11 am PT with Dr. Gish! Link here: https://bit.ly/3gHpjbk  ...
10/28/2022

It is not too late to register for the live webinar today at 11 am PT with Dr. Gish! Link here: https://bit.ly/3gHpjbk

Address

9950 Research Drive
Irvine, CA
92618

Alerts

Be the first to know and let us send you an email when Helio Genomics posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram